News & Events

Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers

January 12, 2015 Critical Path Institute Secures Additional Regulatory Support For Kidney Safety Biomarkers EMA Letter of Support Opens Door for Clinical Qualification TUCSON, Ariz., January 12, 2015 – The Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) issued a first-of-its kind Biomarker Letter of Support for two essential kidney safety […]

C-Path and IMI 2nd Annual Meeting

  Accelerating the Development of Drugs, Diagnostics, and Devices: Partnerships to Expand the Precompetitive Space  Wednesday, December 3, 2014 Bethesda, MD, USA On December 3, 2014, the Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) convened an international group of thought leaders to identify new ways to collaborate and achieve a common goal of a […]

Conference Highlights Public Private Partnership Role in Medical Product Development

December 3, 2014 | Download PDF      Conference Highlights Public Private Partnership Role in Medical Product Development Global organizations convene cross-sector thought leaders to discuss public-private partnerships BETHESDA, MD, December 3, 2014—Today, the Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) are convening an international group of thought leaders to identify new ways to […]